Cerus (STU:CU2) Total Liabilities : €127.9 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Cerus Total Liabilities?

Cerus's Total Liabilities for the quarter that ended in Mar. 2024 was €127.9 Mil.

Cerus's quarterly Total Liabilities declined from Sep. 2023 (€146.94 Mil) to Dec. 2023 (€132.33 Mil) and declined from Dec. 2023 (€132.33 Mil) to Mar. 2024 (€127.86 Mil).

Cerus's annual Total Liabilities increased from Dec. 2021 (€134.42 Mil) to Dec. 2022 (€141.16 Mil) but then declined from Dec. 2022 (€141.16 Mil) to Dec. 2023 (€132.33 Mil).

Cerus Total Liabilities Historical Data

The historical data trend for Cerus's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cerus Total Liabilities Chart

Cerus Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

97.64

96.68

134.42

141.16

132.33

Cerus Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															139.89	135.84	146.94	132.33	127.86

Cerus Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cerus's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	61.917	+	(67.443	+	2.967
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	132.3

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	181.335	-	49.008
	=	132.3

Cerus's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	52.665	+	(72.031	+	3.16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	127.9

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	174.005	-	46.149
	=	127.9

Cerus Total Liabilities Related Terms

Thank you for viewing the detailed overview of Cerus's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cerus (STU:CU2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cerus Corp (STU:CU2) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

CERS:USA

Address

1220 Concord Avenue, Suite 600, Concord, CA, USA, 94520

Website

http://www.cerus.com

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Cerus (STU:CU2) Headlines

No Headlines